Category: Press Release - Page 206 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Novamind Announces Closing of Oversubscribed Private Placement

Novamind Announces Closing of Oversubscribed Private Placement

Post published:July 14, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Post published:July 14, 2020
Post category:Press Release

Read more about the article Champignon Provides Corporate Update

Champignon Provides Corporate Update

Post published:July 13, 2020
Post category:Press Release

Read more about the article ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

Post published:July 9, 2020
Post category:Press Release

Read more about the article MagicMed Industries Files First Psychedelic Derivative Patent

MagicMed Industries Files First Psychedelic Derivative Patent

Post published:July 9, 2020
Post category:Press Release

Read more about the article Pharmadrug Inc. Provides Update on Debt Restructuring

Pharmadrug Inc. Provides Update on Debt Restructuring

Post published:July 9, 2020
Post category:Press Release

Read more about the article Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

Post published:July 9, 2020
Post category:Press Release

Read more about the article Osoyoos Provides Corporate Update on AI Pharma Acquisition

Osoyoos Provides Corporate Update on AI Pharma Acquisition

Post published:July 8, 2020
Post category:Press Release

Read more about the article Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Post published:July 7, 2020
Post category:Press Release

Read more about the article Professor David Nutt Joins AWAKN Life Sciences

Professor David Nutt Joins AWAKN Life Sciences

Post published:July 7, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.